Mistura says Homs terror attacks attempt to derail Geneva talksWorld February 26, 5:49
Annular eclipse will be visible in South America, Africa on Feb 26Science & Space February 26, 3:24
HNC expects Trump to correct Obama's mistakes in Syria - delegation headWorld February 26, 3:08
War on terror to dominate Geneva talks — Syrian UN envoyWorld February 25, 23:48
Russian skier wins gold in skiathlon at 2017 FIS Nordic World Ski ChampionshipsSport February 25, 17:46
Top US Air Force general points to growing conflict potential in Syrian airspaceWorld February 25, 17:17
Iran relies on Russia’s support in production of fuel for nuclear power plantsBusiness & Economy February 25, 16:20
Ukrainian military capture Donetsk water purification plant — spokesmanWorld February 25, 15:05
Azerbaijan and Armenia report armed clashes in Karabakh conflict areaWorld February 25, 11:45
KALUGA, June 5. /TASS/. A new pharmaceutical plant, Nearmedic Pharma, located on the territory of a major innovation and industrial Kaluga region, in central Russia, is starting manufacturing medicines.
The project worth $73 million is implemented in cooperation with the national holding company Nearmedic and the Russian Corporation of Nanotechnologies, the press service of Nearmedic Plus told TASS.
The new plant complies with international standards GMP, ISO and FDA. The total annual output reaches up to 100 million medical products, including anti-viral medications.
"The plant is unique as the whole cycle from the synthesis of incoming substances to manufacturing of finished pharma products comes in the framework of one production unit and the product range is the company’s innovations," the press service said.
All the pharmaceutical companies in Russia's Kaluga region are united in a single pharma cluster which now consists of 54 companies.